Tapewire

Nasdaq · USD

BLFS

BIOLIFE SOLUTIONS INC

Export transactions ↓
Tapewire entity
4614
SEC CIK
0000834365
Parsed reports
1,001

Last 12 months

Inside the activity.

0 purchase rows · 39 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025014
Dec 202508
Jan 202605
Feb 202600
Mar 202609
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 24, 2021 Filed May 27, 2021 00:01 UTC SaleCommon Stock 1,250 $31.61 $39,512.50
Disclosure

SEC source: 0001437749-21-013450 · rdgdoc.xml · nonDerivative · entry 1

Schick Joseph C · CIK 0001592238 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,375

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.61 to $31.63, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 24, 2021 Filed May 27, 2021 00:01 UTC
Foster Karen A.Chief Quality Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 16,332 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-013449 · rdgdoc.xml · derivative · entry 3

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,993

Underlying: Common Stock · 16,332 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 163,323 shares of common stock which vested in two equal installments on March 8, 2018 and March 8, 2019.

Read SEC document
May 24, 2021 Filed May 27, 2021 00:01 UTC
Foster Karen A.Chief Quality Officer
SaleCommon Stock 16,332 $31.44 $513,478.08
Disclosure

SEC source: 0001437749-21-013449 · rdgdoc.xml · nonDerivative · entry 2

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,648

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.06 to $32.26 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 24, 2021 Filed May 27, 2021 00:01 UTC
Foster Karen A.Chief Quality Officer
Exercise / conversionCommon Stock 16,332 $1.64 $26,784.48
Disclosure

SEC source: 0001437749-21-013449 · rdgdoc.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,980

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 19, 2021 Filed May 20, 2021 00:01 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-012837 · rdgdoc.xml · derivative · entry 6

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,707

Underlying: Common Stock · 10,000 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 197,707 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.

Read SEC document
May 19, 2021 Filed May 20, 2021 00:01 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
SaleCommon Stock 10,000 $31.45 $314,500.00
Disclosure

SEC source: 0001437749-21-012837 · rdgdoc.xml · nonDerivative · entry 4

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,679

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.13 to $31.83, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 19, 2021 Filed May 20, 2021 00:01 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionCommon Stock 10,000 $1.64 $16,400.00
Disclosure

SEC source: 0001437749-21-012837 · rdgdoc.xml · nonDerivative · entry 3

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,679

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 17, 2021 Filed May 18, 2021 00:00 UTC SaleCommon Stock 2,500 $29.06 $72,650.00
Disclosure

SEC source: 0001437749-21-012572 · rdgdoc.xml · nonDerivative · entry 1

Hinson Andrew G · CIK 0001389410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,461

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

Read SEC document
May 17, 2021 Filed May 20, 2021 00:01 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-012837 · rdgdoc.xml · derivative · entry 5

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,707

Underlying: Common Stock · 10,000 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 197,707 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.

Read SEC document
May 17, 2021 Filed May 20, 2021 00:01 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
SaleCommon Stock 10,000 $30.12 $301,200.00
Disclosure

SEC source: 0001437749-21-012837 · rdgdoc.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,679

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.20 to $30.63, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 17, 2021 Filed May 20, 2021 00:01 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionCommon Stock 10,000 $1.64 $16,400.00
Disclosure

SEC source: 0001437749-21-012837 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,679

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 14, 2021 Filed May 18, 2021 00:00 UTC
Berard ToddChief Marketing Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 6,160 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-012571 · rdgdoc.xml · derivative · entry 6

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,925

Underlying: Common Stock · 6,160 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 123,209 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.

Read SEC document
May 14, 2021 Filed May 18, 2021 00:00 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 6,160 $29.68 $182,828.80
Disclosure

SEC source: 0001437749-21-012571 · rdgdoc.xml · nonDerivative · entry 4

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,566

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.90 to $30.12 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 14, 2021 Filed May 18, 2021 00:00 UTC
Berard ToddChief Marketing Officer
Exercise / conversionCommon Stock 6,160 $1.64 $10,102.40
Disclosure

SEC source: 0001437749-21-012571 · rdgdoc.xml · nonDerivative · entry 3

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,726

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 13, 2021 Filed May 18, 2021 00:00 UTC
Berard ToddChief Marketing Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 6,160 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-012571 · rdgdoc.xml · derivative · entry 5

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,085

Underlying: Common Stock · 6,160 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 123,209 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.

Read SEC document
May 13, 2021 Filed May 18, 2021 00:00 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 6,160 $29.52 $181,843.20
Disclosure

SEC source: 0001437749-21-012571 · rdgdoc.xml · nonDerivative · entry 2

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,566

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.02 to $30.70 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 13, 2021 Filed May 18, 2021 00:00 UTC
Berard ToddChief Marketing Officer
Exercise / conversionCommon Stock 6,160 $1.64 $10,102.40
Disclosure

SEC source: 0001437749-21-012571 · rdgdoc.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,726

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 06, 2021 Filed May 7, 2021 00:00 UTC
Rice MichaelDirector · CEO
Exercise / conversionEmployee Stock Option · Derivative 11,461 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-011203 · rdgdoc.xml · derivative · entry 6

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,460

Underlying: Common Stock · 11,461 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 114,613 shares vested on March 8, 2018 and 114,613 shares vested on March 8, 2019.

Read SEC document
May 06, 2021 Filed May 7, 2021 00:00 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 11,461 $30.41 $348,529.01
Disclosure

SEC source: 0001437749-21-011203 · rdgdoc.xml · nonDerivative · entry 4

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,014

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.93 to $30.98, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 06, 2021 Filed May 7, 2021 00:00 UTC
Rice MichaelDirector · CEO
Exercise / conversionCommon Stock 11,461 $1.64 $18,796.04
Disclosure

SEC source: 0001437749-21-011203 · rdgdoc.xml · nonDerivative · entry 3

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 282,475

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2021 Filed May 7, 2021 00:00 UTC
Rice MichaelDirector · CEO
Exercise / conversionEmployee Stock Option · Derivative 11,461 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-011203 · rdgdoc.xml · derivative · entry 5

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,921

Underlying: Common Stock · 11,461 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 114,613 shares vested on March 8, 2018 and 114,613 shares vested on March 8, 2019.

Read SEC document
May 04, 2021 Filed May 7, 2021 00:00 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 11,461 $30.15 $345,549.15
Disclosure

SEC source: 0001437749-21-011203 · rdgdoc.xml · nonDerivative · entry 2

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,014

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.70 to $33.51, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 04, 2021 Filed May 7, 2021 00:00 UTC
Rice MichaelDirector · CEO
Exercise / conversionCommon Stock 11,461 $1.64 $18,796.04
Disclosure

SEC source: 0001437749-21-011203 · rdgdoc.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 282,475

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2021 Filed May 14, 2021 00:00 UTC
Tenney DustyCOO and President
GrantRestricted Stock Award · Derivative 6,415 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001437749-21-012161 · rdgdoc.xml · derivative · entry 2

Tenney Dusty · CIK 0001860933 · COO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,415

Underlying: Common Stock · 6,415 shares

Expires not disclosed

F2 · shares: The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period.

F2 · derivative.exercise_date: The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period.

F2 · derivative.expiration_date: The restricted stock was granted pursuant to the Plan. The restricted stock will vest as to between 0% and 200% of the reported number of shares in column 5 based on the registrant's total shareholder return during the period beginning on January 1, 2021 through December 31, 2022 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date) and will vest on the date on which the registrant's board of directors determine the total shareholder return for the period.

Read SEC document
May 03, 2021 Filed May 14, 2021 00:00 UTC
Tenney DustyCOO and President
GrantCommon Stock 32,079 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-21-012161 · rdgdoc.xml · nonDerivative · entry 1

Tenney Dusty · CIK 0001860933 · COO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,079

F1 · price: Restricted stock granted pursuant to the Biolife Solutions 2013 Performance Incentive Plan (the "Plan"), as amended, of Biolife Solutions, Inc. (the "Company") on July 17, 2020 and vests 25% on the first anniversary of the grant date and thereafter yearly, in 4 equal annual installments. The restricted stock was granted to the reporting person as part of the reporting person's compensation for service to the Company.

Read SEC document
April 21, 2021 Filed Apr 22, 2021 00:02 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-009509 · rdgdoc.xml · derivative · entry 6

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,707

Underlying: Common Stock · 10,000 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 197,707 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.

Read SEC document
April 21, 2021 Filed Apr 22, 2021 00:02 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
SaleCommon Stock 10,000 $32.26 $322,600.00
Disclosure

SEC source: 0001437749-21-009509 · rdgdoc.xml · nonDerivative · entry 4

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,679

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.44 to $32.87, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 21, 2021 Filed Apr 22, 2021 00:02 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionCommon Stock 10,000 $1.64 $16,400.00
Disclosure

SEC source: 0001437749-21-009509 · rdgdoc.xml · nonDerivative · entry 3

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,679

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 21, 2021 Filed Jun 5, 2021 00:30 UTC Exercise / conversionEmployee Stock Option · Derivative 10,714 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001437749-21-014195 · rdgdoc.xml · derivative · entry 2

Hinson Andrew G · CIK 0001389410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,714 shares

Expires 2022-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 21, 2021 Filed Jun 5, 2021 00:30 UTC Exercise / conversionCommon Stock 10,714 $1.12 $11,999.68
Disclosure

SEC source: 0001437749-21-014195 · rdgdoc.xml · nonDerivative · entry 1

Hinson Andrew G · CIK 0001389410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,175

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The number of securities reported in Column 5 is the number of securities beneficially owned as of June 4, 2021.

Read SEC document
April 20, 2021 Filed Apr 22, 2021 00:01 UTC
Schulz MarcusChief Revenue Officer
SaleCommon Stock 650 $32.10 $20,865.00
Disclosure

SEC source: 0001437749-21-009507 · rdgdoc.xml · nonDerivative · entry 1

Schulz Marcus · CIK 0001812702 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,145

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

Read SEC document
April 19, 2021 Filed Apr 22, 2021 00:02 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-009509 · rdgdoc.xml · derivative · entry 5

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 167,707

Underlying: Common Stock · 10,000 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 197,707 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.

Read SEC document
April 19, 2021 Filed Apr 22, 2021 00:02 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
SaleCommon Stock 10,000 $32.62 $326,200.00
Disclosure

SEC source: 0001437749-21-009509 · rdgdoc.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,679

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.45 to $33.02, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 19, 2021 Filed Apr 22, 2021 00:02 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionCommon Stock 10,000 $1.64 $16,400.00
Disclosure

SEC source: 0001437749-21-009509 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,679

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 19, 2021 Filed Apr 22, 2021 00:01 UTC
Foster Karen A.Chief Quality Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 16,332 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-009508 · rdgdoc.xml · derivative · entry 3

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,325

Underlying: Common Stock · 16,332 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 163,323 shares of common stock which vested in two equal installments on March 8, 2018 and March 8, 2019.

Read SEC document
April 19, 2021 Filed Apr 22, 2021 00:01 UTC
Foster Karen A.Chief Quality Officer
SaleCommon Stock 16,332 $32.58 $532,096.56
Disclosure

SEC source: 0001437749-21-009508 · rdgdoc.xml · nonDerivative · entry 2

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,648

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.45 to $33.02 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 19, 2021 Filed Apr 22, 2021 00:01 UTC
Foster Karen A.Chief Quality Officer
Exercise / conversionCommon Stock 16,332 $1.64 $26,784.48
Disclosure

SEC source: 0001437749-21-009508 · rdgdoc.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,980

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 16, 2021 Filed Apr 20, 2021 00:55 UTC
Berard ToddChief Marketing Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 6,160 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-009292 · rdgdoc.xml · derivative · entry 6

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,245

Underlying: Common Stock · 6,160 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 123,209 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.

Read SEC document
April 16, 2021 Filed Apr 20, 2021 00:55 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 6,160 $33.38 $205,620.80
Disclosure

SEC source: 0001437749-21-009292 · rdgdoc.xml · nonDerivative · entry 4

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,566

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.92 to $33.78 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 16, 2021 Filed Apr 20, 2021 00:55 UTC
Berard ToddChief Marketing Officer
Exercise / conversionCommon Stock 6,160 $1.64 $10,102.40
Disclosure

SEC source: 0001437749-21-009292 · rdgdoc.xml · nonDerivative · entry 3

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,726

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 15, 2021 Filed Apr 16, 2021 01:43 UTC SaleCommon Stock 5,000 $33.69 $168,450.00
Disclosure

SEC source: 0001437749-21-009069 · rdgdoc.xml · nonDerivative · entry 8

DE GREEF RODERICK · CIK 0001241181 · CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,538

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 17, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.48 to $34.20, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 15, 2021 Filed Apr 20, 2021 00:55 UTC
Berard ToddChief Marketing Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 6,160 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-009292 · rdgdoc.xml · derivative · entry 5

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,405

Underlying: Common Stock · 6,160 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 123,209 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.

Read SEC document
April 15, 2021 Filed Apr 20, 2021 00:55 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 6,160 $33.76 $207,961.60
Disclosure

SEC source: 0001437749-21-009292 · rdgdoc.xml · nonDerivative · entry 2

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,566

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.45 to $34.21 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 15, 2021 Filed Apr 20, 2021 00:55 UTC
Berard ToddChief Marketing Officer
Exercise / conversionCommon Stock 6,160 $1.64 $10,102.40
Disclosure

SEC source: 0001437749-21-009292 · rdgdoc.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,726

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 15, 2021 Filed Apr 20, 2021 00:54 UTC SaleCommon Stock 512 $33.80 $17,305.60
Disclosure

SEC source: 0001437749-21-009291 · rdgdoc.xml · nonDerivative · entry 2

Hinson Andrew G · CIK 0001389410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,961

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

Read SEC document
April 15, 2021 Filed Apr 20, 2021 00:54 UTC SaleCommon Stock 1,988 $33.80 $67,194.40
Disclosure

SEC source: 0001437749-21-009291 · rdgdoc.xml · nonDerivative · entry 1

Hinson Andrew G · CIK 0001389410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,473

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

Read SEC document
April 14, 2021 Filed Apr 16, 2021 01:43 UTC SaleCommon Stock 5,000 $33.83 $169,150.00
Disclosure

SEC source: 0001437749-21-009069 · rdgdoc.xml · nonDerivative · entry 7

DE GREEF RODERICK · CIK 0001241181 · CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,538

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 17, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.62 to $34.63, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 13, 2021 Filed Apr 16, 2021 01:43 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,959 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-009069 · rdgdoc.xml · derivative · entry 11

DE GREEF RODERICK · CIK 0001241181 · CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,959 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 13, 2021 Filed Apr 16, 2021 01:43 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 960 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-009069 · rdgdoc.xml · derivative · entry 10

DE GREEF RODERICK · CIK 0001241181 · CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,959

Underlying: Common Stock · 960 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 13, 2021 Filed Apr 16, 2021 01:43 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 4,000 $0.00 Strike: $1.81 $0.00
Disclosure

SEC source: 0001437749-21-009069 · rdgdoc.xml · derivative · entry 9

DE GREEF RODERICK · CIK 0001241181 · CFO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,000 shares

Expires 2026-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: On May 3, 2016, the reporting person was granted an option to purchase 234,000 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.